EMEA-000718-PIP01-09-M06

Key facts

Invented name
Adempas
Active substance
riociguat
Therapeutic area
Cardiovascular diseases
Decision number
P/0289/2016
PIP number
EMEA-000718-PIP01-09-M06
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral liquid
Condition(s) / indication(s)
Treatment of pulmonary hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Bayer Pharma AG
Germany
Tel. +49 3030 0139003
Fax +49 3046 895333
E-mail: clinical-trials-contact@bayer.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating